Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalOperating Expenses
Others
Ratios

Inogen (INGN) EBT (2016 - 2022)

Inogen has reported EBT over the past 10 years, most recently at -$9.4 million for Q3 2022.

  • Quarterly results put EBT at -$9.4 million for Q3 2022, down 259.15% from a year ago — trailing twelve months through Sep 2022 was -$21.4 million (down 297.78% YoY), and the annual figure for FY2021 was $1.0 million, up 116.06%.
  • EBT for Q3 2022 was -$9.4 million at Inogen, down from -$3.4 million in the prior quarter.
  • Over the last five years, EBT for INGN hit a ceiling of $13.7 million in Q2 2019 and a floor of -$14.5 million in Q4 2021.
  • Median EBT over the past 5 years was $5.8 million (2018), compared with a mean of $2.9 million.
  • Biggest five-year swings in EBT: soared 409.93% in 2021 and later plummeted 259.15% in 2022.
  • Inogen's EBT stood at $5.8 million in 2018, then plummeted by 172.76% to -$4.2 million in 2019, then decreased by 22.85% to -$5.2 million in 2020, then tumbled by 178.77% to -$14.5 million in 2021, then surged by 34.97% to -$9.4 million in 2022.
  • The last three reported values for EBT were -$9.4 million (Q3 2022), -$3.4 million (Q2 2022), and -$14.5 million (Q4 2021) per Business Quant data.